Search

Author/Creator Tabar, Cynthia

1. Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial. Issue 12 (2nd December 2021)

Authors:
Pepin, Stephanie; Nicolas, Jean-François; Szymanski, Henryk; Leroux-Roels, Isabel; Schaum, Thomas; Bonten, Marc; Icardi, Giancarlo; Shrestha, Anju; Tabar, Cynthia
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 17:Issue 12(2021)
Page Start:
5475
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study. Issue 5 (4th May 2019)

Authors:
Hu, Yuemei; Chu, Kai; Lavis, Nathalie; Li, Xiaoling; Liang, Bill; Liu, Shuzhen; Shao, Ming; Shu, Jean-Denis; Tabar, Cynthia; Samson, Sandrine
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 15:Issue 5(2019)
Page Start:
1066
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Persistence of Hepatitis B Immune Memory Until 6 Years of Age Following Hexavalent DTaP-IPV-HB-PRP~T Vaccination in a 3-, 5- and 11- to 12-month Schedule and Response to a Subsequent Hepatitis B Challenge Vaccination. Issue 1 (January 2021)

Authors:
Virta, Miia; Soininen, Anu; Patel, Dhaval M.; Petit, Céline; Tabar, Cynthia; Lyabis, Olga
Journal:
Pediatric infectious disease journal
Issue:
Volume 40:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗